Resultats globals: 31 registres trobats en 0.03 segons.
Articles, 29 registres trobats
Documents de recerca, 2 registres trobats
Articles 29 registres trobats  1 - 10següentfinal  anar al registre:
1.
12 p, 613.3 KB One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer : Spanish Multicenter Study (ENDO-OSNA) / Diestro, María Dolores (Hospital Universitario La Paz) ; Berjón, Alberto (Hospital Universitario La Paz) ; Zapardiel, Ignacio (Hospital Universitario La Paz) ; Yébenes, Laura (Hospital Universitario La Paz) ; Ruiz, Irune (Hospital Universitario Donostia Osakidetza) ; Lekuona, Arantza (Hospital Universitario Donostia Osakidetza) ; Rezola, Marta (Hospital Universitario Donostia Osakidetza) ; Jaunarena, Ibon (Hospital Universitario Donostia Osakidetza) ; Siegrist, Jaime (Hospital Universitario La Paz) ; Sánchez-Pastor, Margarita (Hospital Universitario La Paz) ; Cuadra, María (OSI Araba Hospital Universitario) ; Sagasta, Amaia (OSI Araba Hospital Universitario) ; Guerra, Isabel (OSI Araba Hospital Universitario) ; Lete, Luis I. (OSI Araba Hospital Universitario) ; Roldán, Fernando (Hospital Clínico Universitario Lozano Blesa) ; Marta, Carlo B. (Hospital Clínico Universitario Lozano Blesa) ; Boillos, María J. (Hospital Clínico Universitario Lozano Blesa) ; Cardiel, María J. (Hospital Clínico Universitario Lozano Blesa) ; López-de la Manzanara, Carlos (Hospital General Universitario Ciudad Real) ; Relea, Fernanda (Hospital General Universitario Ciudad Real) ; Coronado, Pluvio (Hospital Clínico San Carlos (Madrid)) ; Pascual, Alejandro (Hospital Clínico San Carlos (Madrid)) ; Román, María J. (Hospital General Universitari Dr. Balmis) ; Peiró, Gloria (Hospital General Universitari Dr. Balmis) ; Matute, Luis J. (Hospital Universitario y Politécnico La Fe) ; Montero, Beatriz (Hospital Universitario y Politécnico La Fe) ; Muruzábal, Juan C. (Complejo Hospitalario Universitario Navarra) ; Guarch, Rosa (Complejo Hospitalario Universitario Navarra) ; Zorrero, Cristina (Hospital Fundación IVO) ; Calatrava, Ana (Hospital Fundación IVO, 46009 Valencia) ; Ribot, Laia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Costa, Irmgard (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Hernández Gutierrez, Alicia (Hospital Universitario La Paz) ; Hardisson, David (Hospital Universitario La Paz) ; Universitat Autònoma de Barcelona
One-step nucleic acid amplification (OSNA) is an automated molecular diagnostic assay used to detect metastases by analyzing the levels of cytokeratin 19 mRNA in whole lymph nodes. It has been validated as an accurate and reliable tool for staging in several types of cancers and is included in the National Institute for Health and Care Excellence guidelines for the management of breast cancer. [...]
2021 - 10.3390/cancers13174465
Cancers, Vol. 13 (september 2021)  
2.
9 p, 667.7 KB Mutational spectrum of Duchenne muscular dystrophy in Spain : Study of 284 cases Espectro mutacional de la distrofia muscular de Duchenne en España: estudio de 284 casos / Vieitez, I. (Complexo Hospitalario Universitario de Vigo (CHUVI)) ; Gallano, Pia (Institut d'Investigació Biomèdica Sant Pau) ; González-Quereda, Lidia (Institut d'Investigació Biomèdica Sant Pau) ; Borrego, S. (Instituto de Salud Carlos III) ; Marcos, I. (Instituto de Salud Carlos III) ; Millán, J.M. (Instituto de Salud Carlos III) ; Jairo, T. (Instituto de Salud Carlos III) ; Prior, C. (Hospital Universitario La Paz (Madrid)) ; Molano, J. (Hospital Universitario La Paz (Madrid)) ; Trujillo-Tiebas, M.J. (Instituto de Salud Carlos III) ; Gallego-Merlo, J. (Instituto de Salud Carlos III) ; García-Barcina, M. (Zuwe Hofpoort Hospital) ; Fenollar, M. (Hospital Clínico San Carlos (Madrid)) ; Navarro, C. (Complexo Hospitalario Universitario de Vigo (CHUVI)) ; Universitat Autònoma de Barcelona
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive neuromuscular disease that affects one in 3500 live-born males. The total absence of dystrophin observed in DMD patients is generally caused by mutations that disrupt the reading frame of the DMD gene, and about 80% of cases harbour deletions or duplications of one or more exons. [...]
2017 - 10.1016/j.nrl.2015.12.009
Neurología, Vol. 32 Núm. 6 (julio 2017) , p. 377-385  
3.
13 p, 12.4 MB Efficient detection of African Swine Fever Virus using minimal equipment through a LAMP PCR method / Bohórquez Garzón, José Alejandro (University of Illinois at Urbana-Champaign. College of Veterinary Medicine) ; Lanka, Saraswathi (University of Illinois at Urbana-Champaign. College of Veterinary Medicine) ; Rosell, Rosa (Generalitat de Catalunya. Departament d'Acció Climàtica, Alimentació i Agenda Rural) ; Pérez-Simó, Marta (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ; Alberch, Mònica (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ; Rodriguez, Fernando (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ; Ganges, Llilianne (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ; Maddox, Carol W. (University of Illinois at Urbana-Champaign. College of Veterinary Medicine)
African swine fever virus (ASFV) currently represents the biggest threat to the porcine industry worldwide, with high economic impact and severe animal health and welfare concerns. Outbreaks have occurred in Europe and Asia since ASFV was reintroduced into the continent in 2007 and, in 2021, ASFV was detected in the Caribbean, raising alarm about the reemergence of the virus in the Americas. [...]
2023 - 10.3389/fcimb.2023.1114772
Frontiers in cellular and infection microbiology, Vol. 13 (january 2023)  
4.
14 p, 1.9 MB Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma / Frontzek, Fabian (University Hospital of Münster (Alemanya)) ; Staiger, Annette M. (Robert Bosch Hospital) ; Zapukhlyak, Myroslav (University Hospital of Münster (Alemanya)) ; Xu, Wendan (University Hospital of Münster (Alemanya)) ; Bonzheim, Irina (University Hospital of Tübingen (Alemanya)) ; Borgmann, Vanessa (University Hospital of Tübingen (Alemanya)) ; Sander, Philip (University Hospital of Tübingen (Alemanya)) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Heming, Jan-Niklas (University Hospital of Münster (Alemanya)) ; Berning, Philipp (University Hospital of Münster (Alemanya)) ; Wullenkord, Ramona (University Hospital of Münster (Alemanya)) ; Erdmann, Tabea (University Hospital of Münster (Alemanya)) ; Lutz, Mathias (University Hospital of Münster (Alemanya)) ; Veratti, Pia (University Hospital Freiburg) ; Ehrenfeld, Sophia (University of Freiburg) ; Wienand, Kirsty (University Medical Center Göttingen) ; Horn, Heike (Robert Bosch Hospital) ; Goodlad, John R. (Queen Elizabeth University Hospital) ; Wilson, Matthew R. (Beatson West of Scotland Cancer Centre (Glasgow, Regne Unit)) ; Anagnostopoulos, Ioannis (Charité - Universitätsmedizin Berlin) ; Lamping, Mario (Charité - Universitätsmedizin Berlin) ; González Barca, Eva (Universitat de Barcelona) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Salar, Antonio (Hospital del Mar (Barcelona, Catalunya)) ; Castellvi, Josep (Hospital Universitari Vall d'Hebron) ; Abrisqueta, Pau (Hospital Universitari Vall d'Hebron) ; Menarguez, Javier (Hospital General Universitario Gregorio Marañón) ; Aldámiz-Echevarría, T (Hospital General Universitario Gregorio Marañón) ; Richter, Julia (Christian-Albrechts-University) ; Klapper, Wolfram (Christian-Albrechts-University) ; Tzankov, Alexander (University Hospital Basel (Basilea, Suïssa)) ; Dirnhofer, Stefan (University Hospital Basel (Basilea, Suïssa)) ; Rosenwald, Andreas (University of Würzburg) ; Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Lenz, Peter (Department of Physics. University of Marburg) ; Miething, C. (German Cancer Research Center) ; Hartmann, Wolfgang (University Hospital of Münster (Alemanya)) ; Chapuy, Björn (University Medical Center Göttingen) ; Fend, Falko (University Hospital of Tübingen (Alemanya)) ; Ott, Gustav (Department of Clinical Pathology. Robert Bosch Hospital) ; Navarro, José-Tomás (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Grau, Michael (University Hospital of Münster (Alemanya)) ; Lenz, Georg (University Hospital of Münster (Alemanya)) ; Universitat Autònoma de Barcelona
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype frequently associated with immunosuppression. Clinically, patients with PBL are characterized by poor outcome. The current understanding of the molecular pathogenesis is limited. [...]
2021 - 10.1038/s41467-021-25405-w
Nature communications, Vol. 12 Núm. 1 (january 2021) , p. 5183  
5.
12 p, 3.1 MB Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer / Saigí, Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cucurull, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domènech, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernández, Ainhoa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martinez-Cardús, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pros, Eva (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sanchez-Cespedes, Montse (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Identifying molecular oncogenic drivers is crucial for precision oncology. Genetic rearrangements, including gene fusions and gene amplification, involving and activating receptor tyrosine kinases (RTKs) are recurrent in solid tumors, particularly in non-small cell lung cancer. [...]
2022 - 10.1016/j.ctrv.2022.102430
Cancer Treatment Reviews, Vol. 109 (september 2022) , p. 102430  
6.
9 p, 1.1 MB Refinement of computational identification of somatic copy number alterations using DNA methylation microarrays illustrated in cancers of unknown primary / Blecua, Pedro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Davalos, Veronica (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; De Villasante, Izar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Merkel, Angelika (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Musulén, Eva (Hospital Universitari General de Catalunya) ; Coll-Sanmartin, Laia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
High-throughput genomic technologies are increasingly used in personalized cancer medicine. However, computational tools to maximize the use of scarce tissues combining distinct molecular layers are needed. [...]
2022 - 10.1093/bib/bbac161
Briefings in Bioinformatics, Vol. 23 Núm. 5 (september 2022) , p. bbac161  
7.
14 p, 445.0 KB Targeting HER2 in non-small-cell lung cancer (NSCLC) : a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations / Riudavets, M. (Department of Cancer Medicine. Gustave Roussy Cancer Campus) ; Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ; Abdayem, P. (Department of Cancer Medicine. Gustave Roussy Cancer Campus) ; Planchard, D. (Department of Cancer Medicine. Gustave Roussy Cancer Campus)
Non-small-cell lung cancer (NSCLC) harbouring HER2 alterations is now considered a distinct molecular subtype. The activation of HER2 in NSCLC occurs via three mechanisms, i. e. gene mutation (1%-4% of cases), gene amplification (2%-5%) and protein overexpression (2%-30%), with different prognostic and predictive outcomes. [...]
2021 - 10.1016/j.esmoop.2021.100260
ESMO open, Vol. 6 Núm. 5 (october 2021) , p. 100260  
8.
0 p, 567.1 KB Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : clinical and biomarker results from a phase I trial / Schuler, M. (German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany) ; Berardi, R. (Università Politecnica delle Marche-Ospedali Riuniti) ; Lim, W.-T (National Cancer Centre Singapore) ; de Jonge, M. (Erasmus MC Cancer Center, Rotterdam) ; Bauer, Todd M (Sarah Cannon Research Institute, and Tennessee Oncology) ; Azaro, Analía (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Gottfried, M. (Oncology Institute of Meir Medical Center) ; Han, J.Y (Center for Lung Cancer, National Cancer Center (Corea del Sud)) ; Lee, D. H. (University of Ulsan College of Medicine (República de Corea)) ; Wollner, M. (Rambam Health Care Campusm (Israel)) ; Hong, David (MD Anderson Cancer Center (Estats Units d'Amèrica)) ; Vogel, A. (Hannover Medical School (Alemanya)) ; Delmonte, A. (Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori) ; Akimov, Mikhail (Novartis Pharma (Siïssa)) ; Ghebremariam, S. (Oncology Global Development-BDM) ; Cui, X. (Novartis Institutes for Biomedical Research) ; Nwana, N. (Oncology Precision Medicine) ; Giovannini, M. (Novartis Pharmaceuticals Corporation(Estats Units d'Amèrica)) ; Kim, T. M. (Seoul National University Hospital)
Dysregulation of receptor tyrosine kinase MET by various mechanisms occurs in 3%-4% of non-small-cell lung cancer (NSCLC) and is associated with unfavorable prognosis. While MET is a validated drug target in lung cancer, the best biomarker strategy for the enrichment of a susceptible patient population still remains to be defined. [...]
2020 - 10.1016/j.annonc.2020.03.293
Annals of oncology, Vol. 31 (march 2020) , p. 789-797  
9.
16 p, 1.2 MB Development and diagnostic validation of a one-step multiplex RT-PCR assay as a rapid method to detect and identify Nervous Necrosis Virus (NNV) and its variants circulating in the Mediterranean / Errani, Francesca (University of Bologna. Department of Veterinary Medical Sciences) ; Volpe, Enrico (University of Bologna. Department of Veterinary Medical Sciences) ; Riera-Ferrer, Enrique (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Caffara, Monica (University of Bologna. Department of Veterinary Medical Sciences) ; Padrós, Francesc 1965- (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Gustinelli, Andrea (University of Bologna. Department of Veterinary Medical Sciences) ; Fioravanti, Marialetizia (University of Bologna. Department of Veterinary Medical Sciences) ; Ciulli, Sara (University of Bologna. Department of Veterinary Medical Sciences)
Nervous Necrosis Virus (NNV) represents one of the most threatening pathogens for Mediterranean aquaculture. Several NNV strains are currently co-circulating in the Mediterranean Basin with a high prevalence of the RGNNV genotype and the RGNNV/SJNNV reassortant strain and a more limited diffusion of the SJNNV genotype and the SJNNV/RGNNV reassortant. [...]
2022 - 10.1371/journal.pone.0273802
PloS one, Vol. 17 (august 2022)  
10.
10 p, 1.3 MB Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer : a systematic review / Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; de Torres, Inés (Hospital Universitari Vall d'Hebron) ; Semidey, M. Eugenia (Hospital Universitari Vall d'Hebron) ; Trilla, Enrique (Hospital Universitari Vall d'Hebron) ; Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Universitat Autònoma de Barcelona
Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standard for the evaluation of LN metastases despite some limitations, especially low sensitivity in detecting an accurate tumour burden within the LN, as well as a subjective and time-consuming result. [...]
2022 - 10.1186/s12885-022-09355-0
BMC Cancer, Vol. 22 (april 2022)  

Articles : 29 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 2 registres trobats  
1.
39 p, 1.0 MB Estudi de cohorts: Estudi de l'amplificació 9p24 en cèl·lules tumorals de càncer de mama triple negatiu com a predictor de mala resposta a la quimioteràpia neoadjuvant / Alcoverro Godoy, Carmen ; Lerma Puertas, Enrique, dir. (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Universitat Autònoma de Barcelona. Facultat de Medicina
Antecedents: El càncer de mama triple negatiu (CMTN) correspon al 15-20% dels càncers de mama diagnosticats. Aquest subtipus tumoral s'associa a un curs clínic més agressiu, edat d'aparició més precoç, major potencial metastàtic i menors taxes de curació. [...]
Antecedentes: El cáncer de mama triple negativo (CMTN) corresponde al 15-20% de los cáncer de mama diagnosticados. Este subtipo tumoral se asocia a un curso clínico más agresivo, edad de aparición más precoz, mayor potencial metastásico y menores tasas de curación. [...]
Background: Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancers. This tumor subtype is associated with a more aggressive clinical course, earlier age of onset, higher metastatic potential and lower cure rates. [...]

2020
Grau en Medicina [1192]  
2.
48 p, 628.2 KB Macroeconomic fluctuations with HANK & SAM : an analytical approach / Ravn, Morten O. ; Sterk, Vincent
New Keynesian models with unemployment and incomplete markets are rapidly becoming a new workhorse model in macroeconomics. Such models typically require heavy computational methods which may obscure intuition and overlook equilibria. [...]
The ADEMU Working Paper Series is being supported by the European Commission Horizon 2020 European Union funding for Research & Innovation, grant agreement No 649396.

2016 (ADEMU Working Paper Series ; 31)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.